A Study to Evaluate the Efficacy and Safety of Perampanel Monotherapy in Untreated Participants With Focal Onset Seizures With or Without Focal to Bilateral Tonic-clonic Seizures

NCT05533814 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
125
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Eisai Korea Inc.